Disciplined Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$250K Hold
1,022
0.09% 121
2025
Q4
$212K Buy
+1,022
New +$202K 0.08% 118
2023
Q3
Sell
-857
Closed -$142K 840
2023
Q2
$142K Sell
857
-247
-22% -$39.9K 0.08% 132
2023
Q1
$171K Sell
1,104
-4
-0.4% -$646 0.07% 135
2022
Q4
$196K Sell
1,108
-136
-11% -$23.5K 0.1% 115
2022
Q3
$203K Sell
1,244
-234
-16% -$39.6K 0.09% 125
2022
Q2
$262K Buy
1,478
+492
+50% +$87.7K 0.12% 117
2022
Q1
$175K Sell
986
-2
-0.2% -$340 0.07% 131
2021
Q4
$169K Buy
988
+100
+11% +$16.4K 0.07% 119
2021
Q3
$143K Hold
888
0.07% 122
2021
Q2
$146K Buy
888
+233
+36% +$38.6K 0.08% 123
2021
Q1
$108K Buy
655
+23
+4% +$3.72K 0.06% 127
2020
Q4
$100K Sell
632
-285
-31% -$42.1K 0.07% 113
2020
Q3
$137K Sell
917
-92
-9% -$13.6K 0.1% 106
2020
Q2
$142K Sell
1,009
-125
-11% -$18.2K 0.11% 103
2020
Q1
$149K Buy
1,134
+187
+20% +$26.5K 0.14% 95
2019
Q4
$138K Buy
+947
New +$128K 0.12% 103

Other funds holding JNJ

Disciplined Investments's JNJ Position: Q1 2026 in Review

Disciplined Investments held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 1,022 shares worth $250K. The position accounts for 0.09% of the portfolio, ranked #121.

Disciplined Investments first reported a position in JNJ in Q4 2019 and has held it in 17 quarters since. The position peaked at $262K in Q2 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Disciplined Investments held 1,022 shares of Johnson & Johnson worth $250K as of Q1 2026.
  • Disciplined Investments left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.09% of Disciplined Investments's portfolio in Q1 2026, its #121 holding.
  • Disciplined Investments first reported a position in Johnson & Johnson in Q4 2019 and has held it in 17 quarters since.
  • Disciplined Investments's Johnson & Johnson position peaked at $262K in Q2 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Disciplined Investments's 13F filing for Q1 2026, filed 12 May 2026.